CN101559154B - 一种治疗慢性前列腺炎的药物及其制备方法 - Google Patents
一种治疗慢性前列腺炎的药物及其制备方法 Download PDFInfo
- Publication number
- CN101559154B CN101559154B CN200910067045XA CN200910067045A CN101559154B CN 101559154 B CN101559154 B CN 101559154B CN 200910067045X A CN200910067045X A CN 200910067045XA CN 200910067045 A CN200910067045 A CN 200910067045A CN 101559154 B CN101559154 B CN 101559154B
- Authority
- CN
- China
- Prior art keywords
- parts
- prostatitis
- group
- body weight
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 98
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 208000013507 chronic prostatitis Diseases 0.000 title claims abstract description 11
- 241000270666 Testudines Species 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 229940079593 drug Drugs 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 16
- 230000006837 decompression Effects 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 238000004064 recycling Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 16
- 208000004880 Polyuria Diseases 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000035619 diuresis Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 244000261559 Smilax china Species 0.000 abstract 1
- 235000000485 Smilax china Nutrition 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 63
- 241000700159 Rattus Species 0.000 description 33
- 210000002307 prostate Anatomy 0.000 description 27
- 230000037396 body weight Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 238000005303 weighing Methods 0.000 description 14
- 230000008961 swelling Effects 0.000 description 12
- 241000408529 Libra Species 0.000 description 9
- 208000007536 Thrombosis Diseases 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- 238000001802 infusion Methods 0.000 description 9
- 206010018691 Granuloma Diseases 0.000 description 8
- 208000031975 Yang Deficiency Diseases 0.000 description 8
- 230000002567 autonomic effect Effects 0.000 description 8
- 235000010418 carrageenan Nutrition 0.000 description 8
- 229920001525 carrageenan Polymers 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000009161 Espostoa lanata Nutrition 0.000 description 7
- 240000001624 Espostoa lanata Species 0.000 description 7
- 241000700157 Rattus norvegicus Species 0.000 description 7
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 229960001712 testosterone propionate Drugs 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000004377 microelectronic Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000003708 urethra Anatomy 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- 206010069918 Bacterial prostatitis Diseases 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010003178 Arterial thrombosis Diseases 0.000 description 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 3
- 239000011547 Bouin solution Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000001361 intraarterial administration Methods 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012109 statistical procedure Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010070863 Toxicity to various agents Diseases 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007688 Carotid artery thrombosis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004107 Penicillin G sodium Substances 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019369 penicillin G sodium Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910067045XA CN101559154B (zh) | 2009-06-03 | 2009-06-03 | 一种治疗慢性前列腺炎的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910067045XA CN101559154B (zh) | 2009-06-03 | 2009-06-03 | 一种治疗慢性前列腺炎的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101559154A CN101559154A (zh) | 2009-10-21 |
CN101559154B true CN101559154B (zh) | 2011-10-12 |
Family
ID=41218245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910067045XA Expired - Fee Related CN101559154B (zh) | 2009-06-03 | 2009-06-03 | 一种治疗慢性前列腺炎的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101559154B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562114A (zh) * | 2004-03-26 | 2005-01-12 | 刘晓峰 | 一种治疗慢性前列腺炎的药物及其制备方法 |
CN1631388A (zh) * | 2003-12-23 | 2005-06-29 | 王绍金 | 治疗慢性前列腺炎的中药 |
-
2009
- 2009-06-03 CN CN200910067045XA patent/CN101559154B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1631388A (zh) * | 2003-12-23 | 2005-06-29 | 王绍金 | 治疗慢性前列腺炎的中药 |
CN1562114A (zh) * | 2004-03-26 | 2005-01-12 | 刘晓峰 | 一种治疗慢性前列腺炎的药物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
纪延龙.慢性前列腺炎中医治疗近况.《山东中医杂志》.1991, * |
邹强 等.虎杖丹参饮治疗男性抗精子抗体阳性不育症50例疗效观察.《新中医》.2005,(第3期), * |
陈伊.虎杖清浊汤治疗慢性非细菌性前列腺炎76例.《江西中医药》.2008, * |
Also Published As
Publication number | Publication date |
---|---|
CN101559154A (zh) | 2009-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101757566A (zh) | 一种治疗结肠癌的中药组合物及其制备方法 | |
CN101961480A (zh) | 一种治疗便血的中药组合物及其制备方法 | |
CN102284049A (zh) | 一种抗溃疡、减轻放化疗毒副反应的中药复方制剂及其制备方法和用途 | |
CN102225181B (zh) | 治疗前列腺增生症的药物及其制备方法 | |
CN104474473A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN104587252A (zh) | 一种治疗肾结石的中药组合物 | |
CN106177268B (zh) | 一种治疗阳痿的中药组合物及其制备方法 | |
CN104547961A (zh) | 一种治疗胆结石的中药组合物 | |
CN104491459A (zh) | 一种治疗肿瘤的中药组合物 | |
CN101559154B (zh) | 一种治疗慢性前列腺炎的药物及其制备方法 | |
CN100389796C (zh) | 用于治疗慢性前列腺炎的前列舒清中药制剂及其制备方法 | |
CN103341059A (zh) | 一种治疗非淋菌性尿道炎的中药组合物 | |
CN101433649A (zh) | 治疗胆石症的组合物 | |
CN105920488A (zh) | 一种配合电针治疗膀胱过度活动症的中药导入液 | |
CN1241596C (zh) | 治疗膀胱炎的口服中药制剂 | |
CN104840865A (zh) | 一种治疗痛风性关节炎的中药制剂 | |
CN101085165A (zh) | 一种内服治疗病毒性心肌炎的中药组合物 | |
CN103720949A (zh) | 通便肠清胶囊及制备方法 | |
CN103599407B (zh) | 一种用于治疗前列腺炎并伴有失眠多梦的中药组合物 | |
CN103301388B (zh) | 一种治疗慢性胃肠炎症的中药组合物 | |
CN101862376B (zh) | 一种治疗输卵管阻塞性不孕症的药物及其制备方法 | |
CN106266970B (zh) | 一种治疗生产引发子宫内膜炎的中药组合物 | |
CN105687865A (zh) | 一种治疗淋证的中药组合物 | |
CN102895605A (zh) | 一种治疗子宫肌瘤的中药制剂及制备方法 | |
CN105497459A (zh) | 一种治疗妇女带下病的中药制剂及其制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Changchun yinnuo Pharmaceutical Co.,Ltd. Assignor: Liu Xiaofeng Contract record no.: 2011220000039 Denomination of invention: Medicine for treating chronic prostatitis and its preparing method License type: Exclusive License Open date: 20091021 Record date: 20110830 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190123 Address after: 130500 Qunying Road 888, Jiutai Economic Development Zone, Changchun, Jilin Province Patentee after: Changchun yinnuo Pharmaceutical Co.,Ltd. Address before: 130031 No. 23 Exhibition Street, Changchun Economic Development Zone, Jilin Province Patentee before: Liu Xiaofeng |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210316 Address after: No. 999, Xingfu East Road, Zhenlai Economic Development Zone, Baicheng City, Jilin Province 137000 Patentee after: Jilin yinnuoke Pharmaceutical Co.,Ltd. Address before: 130500 Qunying Road 888, Jiutai Economic Development Zone, Changchun, Jilin Province Patentee before: Changchun yinnuo Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111012 |